Refine
Document Type
- Article (6)
Language
- English (6)
Has Fulltext
- yes (6)
Is part of the Bibliography
- no (6)
Keywords
- - (5)
- BCL11B (4)
- homodimerization (2)
- ADCC (1)
- AICC (1)
- CCHC zinc finger (1)
- CRE-ER/lox (1)
- CRISPR/Cas (1)
- Chromosomal aberrations (1)
- FRET (1)
- Fine tiling comparative genomic hybridization (1)
- IL-15 (1)
- LMO1 (1)
- Ligation-mediated PCR (1)
- Lymphoblastic leukaemia (1)
- T-ALL (1)
- TAL1 (1)
- TCL (1)
- TIGER2h (1)
- TIGER2hs (1)
- alpha- beta CD8+ T cells (1)
- chromoplexy (1)
- chromosomal translocations (1)
- chromosome conformation capture (1)
- cutaneous T-cell lymphoma (1)
- deep sequencing (1)
- human (1)
- innateness (1)
- knock-out (1)
- mouse model (1)
- protein expression and purification (1)
- protein folding (1)
- protein-protein docking (1)
- replica-exchange molecular dynamics (1)
- zinc finger (1)
Institute
Publisher
- MDPI (3)
- Frontiers Media S.A. (1)
- S. Karger AG (1)
- Taylor & Francis (1)
BCL11B, an essential transcription factor for thymopoiesis, regulates also vital processes in post-thymic lymphocytes. Increased expression of BCL11B was recently correlated with the maturation of NK cells, whereas reduced BCL11B levels were observed in native and induced T cell subsets displaying NK cell features. We show that BCL11B-depleted CD8+ T cells stimulated with IL-15 acquired remarkable innate characteristics. These induced innate CD8+ (iiT8) cells expressed multiple innate receptors like NKp30, CD161, and CD16 as well as factors regulating migration and tissue homing while maintaining their T cell phenotype. The iiT8 cells effectively killed leukemic cells spontaneously and neuroblastoma spheroids in the presence of a tumor-specific monoclonal antibody mediated by CD16 receptor activation. These iiT8 cells integrate the innate natural killer cell activity with adaptive T cell longevity, promising an interesting therapeutic potential. Our study demonstrates that innate T cells, albeit of limited clinical applicability given their low frequency, can be efficiently generated from peripheral blood and applied for adoptive transfer, CAR therapy, or combined with therapeutic antibodies.